222 related articles for article (PubMed ID: 12629860)
41. [Cutaneous pseudolymphomas].
Piérard-Franchimont C; Arrese J; Piérard GE
Rev Med Liege; 2000 Aug; 55(8):793-7. PubMed ID: 11051777
[TBL] [Abstract][Full Text] [Related]
42. [Cutaneous pseudolymphomas].
Galil-Ogly GA; Vorob'ev AI; Potekaev NS; Sergeev IuV; Olesova OIu; Paklina OV; Bershchanskaia AM; Bal'shun DG
Arkh Patol; 2003; 65(6):3-8. PubMed ID: 14964959
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous B cell lymphomas: standards in diagnostic and clinical work-up. Hints, pitfalls and recent advances.
Oschlies I; Wehkamp U
Histopathology; 2022 Jan; 80(1):184-195. PubMed ID: 34958501
[TBL] [Abstract][Full Text] [Related]
44. Primary cutaneous B-cell lymphoma: a clinically homogeneous entity?
Pimpinelli N; Santucci M; Mori M; Vallecchi C; Giannotti B
J Am Acad Dermatol; 1997 Dec; 37(6):1012-6. PubMed ID: 9418781
[No Abstract] [Full Text] [Related]
45. Disseminated cutaneous B-cell lymphoma mimicking pseudolymphoma over a period of six years.
Gutermuth J; Audring H; Roseeuw D
Am J Dermatopathol; 2004 Jun; 26(3):225-9. PubMed ID: 15166512
[TBL] [Abstract][Full Text] [Related]
46. Cutaneous B-cell lymphoma: important diagnostic tools.
Ferenczi K
G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
[TBL] [Abstract][Full Text] [Related]
47. Approach to dermal-based lymphoid infiltrates and proliferations.
Charli-Joseph Y; Toussaint-Claire S; Lome-Maldonado C; Montante-Montes de Oca D; Ortiz-Hidalgo C
Semin Cutan Med Surg; 2018 Mar; 37(1):61-74. PubMed ID: 29719022
[TBL] [Abstract][Full Text] [Related]
48. Primary Cutaneous Composite Lymphomas.
Chen S; Boyer D; Hristov AC
Arch Pathol Lab Med; 2018 Nov; 142(11):1352-1357. PubMed ID: 30407855
[TBL] [Abstract][Full Text] [Related]
49. A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis.
Arai E; Shimizu M; Hirose T
Hum Pathol; 2005 May; 36(5):505-11. PubMed ID: 15948117
[TBL] [Abstract][Full Text] [Related]
50. [Cutaneous pseudolymphoma caused by carbamazepine].
d'Incan M; Mouillet ML; Roger H; Ferrier MC; Buono JP; Déchelotte P; Bignon YJ; Souteyrand P
Ann Dermatol Venereol; 1998 Jan; 125(1):52-5. PubMed ID: 9747211
[TBL] [Abstract][Full Text] [Related]
51. Classification of cutaneous lymphomas.
Burg G; Dummer R; Kerl H
Dermatol Clin; 1994 Apr; 12(2):213-7. PubMed ID: 8045033
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic study of cutaneous pseudolymphomas.
Lee MW; Lee DK; Choi JH; Moon KC; Koh JK
J Dermatol; 2005 Jul; 32(7):594-601. PubMed ID: 16335878
[TBL] [Abstract][Full Text] [Related]
53. [Item 164--Malignant lymphomas: cutaneous lymphomas].
CEDEF
Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
[No Abstract] [Full Text] [Related]
54. Early detection of cutaneous lymphoma.
Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
[TBL] [Abstract][Full Text] [Related]
55. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
Lan TT; Brown NA; Hristov AC
Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
[TBL] [Abstract][Full Text] [Related]
56. Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop.
Swerdlow SH; Quintanilla-Martinez L; Willemze R; Kinney MC
Am J Clin Pathol; 2013 Apr; 139(4):515-35. PubMed ID: 23525619
[TBL] [Abstract][Full Text] [Related]
57. Primary subcutaneous B-cell lymphoma: case report and literature review.
Alaibac M; Bordignon M; Pennelli N; Aversa S; Fornasa CV; Chiarion V
Acta Derm Venereol; 2008; 88(2):151-4. PubMed ID: 18311443
[TBL] [Abstract][Full Text] [Related]
58. [Mycosis fungoides-type eruptions induced by carbamazepine].
Alvarez-Ruiz S; Delgado Y; Aragües M; Fraga J; Sánchez-Pérez J; Fernández-Herrera J
Actas Dermosifiliogr; 2006; 97(1):43-7. PubMed ID: 16540051
[TBL] [Abstract][Full Text] [Related]
59. Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders.
Kamarashev J; Schaerer L; Burg G; Schmid MH; Müller B; Kempf W
J Cutan Pathol; 2001 Oct; 28(9):448-52. PubMed ID: 11553310
[TBL] [Abstract][Full Text] [Related]
60. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
Burg G; Kempf W; Cozzio A; Feit J; Willemze R; S Jaffe E; Dummer R; Berti E; Cerroni L; Chimenti S; Diaz-Perez JL; Grange F; Harris NL; Kazakov DV; Kerl H; Kurrer M; Knobler R; Meijer CJ; Pimpinelli N; Ralfkiaer E; Russell-Jones R; Sander C; Santucci M; Sterry W; Swerdlow SH; Vermeer MH; Wechsler J; Whittaker S
J Cutan Pathol; 2005 Nov; 32(10):647-74. PubMed ID: 16293178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
